Polyoma BK virus and haemorrhagic cystitis in haematopoietic stem cell transplantation: A changing paradigm

Bone Marrow Transplantation

Volumn 36, Issue 11, 2005, Pages 929-937

  Leung, A Y H ^a   Yuen, K Y ^a   Kwong, Y L ^a,b  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b QUEEN MARY HOSPITAL   (Hong Kong)

Author keywords

BKV; Haematopoietic stem cell transplantation; Haemorrhagic cystitis

Indexed keywords

BLOOD CLOTTING FACTOR 13; BLOOD CLOTTING FACTOR 7A; BUSULFAN; CIDOFOVIR; CIPROFLOXACIN; CONJUGATED ESTROGEN; CYCLOPHOSPHAMIDE; ETOPOSIDE; FIBRIN GLUE; FORMALDEHYDE; GANCICLOVIR; IFOSFAMIDE; LEVOFLOXACIN; MESNA; NALIDIXIC ACID; OPIATE; PENTOSAN POLYSULFATE; PHENAZOPYRIDINE; PROSTAGLANDIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RETINOIC ACID DERIVATIVE;

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ALLOIMMUNITY; BK VIRUS; BLADDER BLEEDING; BLADDER EPITHELIUM; BONE MARROW TOXICITY; CARCINOGENESIS; CELL DAMAGE; CHEMOPROPHYLAXIS; DISEASE SEVERITY; EPITHELIUM CELL; FATALITY; GRAFT VERSUS HOST REACTION; HEMATURIA; HEMORRHAGIC CYSTITIS; HUMAN; NEPHROTOXICITY; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; THROMBOEMBOLISM; VIRUS INFECTION; VIRUS LOAD; VIRUS REACTIVATION; VIRUS REPLICATION; VIRUS TRANSMISSION;

BK VIRUS; CYSTITIS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; POLYOMAVIRUS INFECTIONS; TUMOR VIRUS INFECTIONS; VIRUS ACTIVATION;

EID: 28544448991     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/sj.bmt.1705139     Document Type: Review

References (60)

1. DeVries CR, Freiha FS. Haemorrhagic cystitis: A review. J Urol 1990; 143: 1-9.
2. Bedi A, Miller CB, Hanson JL et al. Association of BK virus with failure of prophylaxis against hemorrhagic cystitis following bone marrow transplantation. J Clin Oncol 1995; 13: 1103-1109.
3. McCarville MB, Hoffer FA, Gingrich JR, Jenkins II JJ. Imaging findings of haemorrhagic cystitis in pediatric oncology patients. Pediatr Radiol 2000; 30: 131-138.
4. Leung AY, Mak R, Lie AK et al. Clinicopathological features and risk factors of clinically overt haemorrhagic cystitis complicating bone marrow transplantation. Bone Marrow Transplantation 2002; 29: 509-513.
5. Shepherd JD, Pringle LE, Barnett MJ et al. Mesna versus hyperhydration for the prevention of cyclophosphamide-induced haemorrhagic cystitis in bone marrow transplantation. J Clin Oncol 1991; 9: 2016-2020.
6. Tsuboi K, Kishi K, Ohmachi K et al. Multivariate analysis of risk factors for haemorrhagic cystitis after hematopoietic stem cell transplantation. Bone Marrow Transplantation 2003; 32: 903-907.
7. Sell A, Bertelsen K, Andersen JE et al. Randomized study of whole-abdomen irradiation versus pelvic irradiation plus cyclophosphamide in treatment of early ovarian cancer. Gynecol Oncol 1990; 37: 367-373.
8. Seber A, Shu XO, Defor T et al. Risk factors for severe haemorrhagic cystitis following BMT. Bone Marrow Transplantation 1999; 23: 35-40.
9. Yamamoto R, Kusumi E, Kami M et al. Late haemorrhagic cystitis after reduced-intensity hematopoietic stem cell transplantation (RIST). Bone Marrow Transplantation 2003; 32: 1089-1095.
10. Cesaro S, Brugiolo A, Faraci M et al. Incidence and treatment of haemorrhagic cystitis in children given hematopoietic stem cell transplantation: A survey from the Italian association of pediatric hematology oncology - bone marrow transplantation group. Bone Marrow Transplantation 2003; 32: 925-931.
11. El-Zimaity M, Saliba R, Chan K et al. Haemorrhagic cystitis after allogeneic hematopoietic stem cell transplantation: Donor type matters. Blood 2004; 103: 4674-4680.
12. Gardner SD, Field AM, Coleman DV, Hulme B. New human papovavirus (BK) isolated from urine after renal transplantation. Lancet 1971; 1: 1253-1257.
13. Hirsch HH, Steiger J. Polyomavirus BK. Lancet Infect Dis 2003; 3: 611-623.
14. Reploeg MD, Storch GA, Clifford DB. BK virus: A clinical review. Clin Infect Dis 2001; 33: 191-202.
15. Binet I, Nickeleit V, Hirsch HH. Polyomavirus infections in transplant recipients. Curr Opin Organ Transplant 2000; 5: 210-216.
16. Tognon M, Corallini A, Martini F et al. Oncogenic transformation by BK virus and association with human tumors. Oncogene 2003; 22: 5192-5200.
17. Cubukcu-Dimopulo O, Greco A, Kumar A et al. BK virus infection in AIDS. Am J Surg Pathol 2000; 24: 145-149.
18. Nickeleit V, Klimkait T, Binet IF et al. Testing for polyomavirus type BK DNA in plasma to identify renal-allograft recipients with viral nephropathy. N Engl J Med 2000; 342: 1309-1315.
19. Kwak EJ, Vilchez RA, Randhawa P et al. Pathogenesis and management of polyomavirus infection in transplant recipients. Clin Infect Dis 2002; 35: 1081-1087.
20. Tavis JE, Walker DL, Gardner SD, Frisque RJ. Nucleotide sequence of the human polyomavirus AS virus, an antigenic variant of BK virus. J Virol 1989; 63: 901-911.
21. Chatterjee M, Weyandt TB, Frisque RJ. Identification of archetype and rearranged forms of BK virus in leukocytes from healthy individuals. J Med Virol 2000; 60: 353-362.
22. Priftakis P, Bogdanovic G, Kalantari M, Dalianis T. Over-representation of point mutations in the Sp1 site of the non-coding control region of BK virus in bone marrow transplanted patients with haemorrhagic cystitis. J Clin Virol 2001; 21: 1-7.
23. Leung AY, Chan MT, Kwong YL. Genotyping of the non-coding control region of BK virus in patients with haemorrhagic cystitis after allogeneic haematopoietic stem cell transplantation. Bone Marrow Transplantation 2005; 35: 531-532.
24. Negrini M, Sabbioni S, Arthur RR et al. Prevalence of the archetypal regulatory region and sequence polymorphisms in nonpassaged BK virus variants. J Virol 1991; 65: 5092-5095.
25. Dolei A, Pietropaolo V, Gomes E et al. Polyomavirus persistence in lymphocytes: Prevalence in lymphocytes from blood donors and healthy personnel of a blood transfusion centre. J Gen Virol 2000; 81: 1967-1973.
26. Azzi A, Cesaro S, Laszlo D et al. Human polyomavirus BK (BKV) load and haemorrhagic cystitis in bone marrow transplantation patients. J Clin Virol 1999; 14: 79-86.
27. Leung AY, Suen CK, Lie AK et al. Quantification of polyoma BK viruria in haemorrhagic cystitis complicating bone marrow transplantation. Blood 2001; 98: 1971-1978.
28. Erard V, Kim HW, Corey L et al. BK DNA viral load in plasma: Evidence for an association with haemorrhagic cystitis in allogeneic hematopoietic cell transplant recipients. Blood 2005 April 21 [epub ahead of print].
29. Leung AY, Chan MT, Yuen KY et al. Ciprofloxacin decreased polyoma BK viruria in patients undergoing allogeneic hematopoietic stem cell transplantation. Clin Infect Dis 2005; 40: 528-537.
30. Erard V, Storer B, Corey L et al. BK virus infection in hematopoietic stem cell transplant recipients: Frequency, risk factors and association with postengraftment haemorrhagic cystitis. Clin Infect Dis 2004; 39: 1861-1865.
31. Ferrazzi E, Peracchi M, Biasolo MA et al. Antiviral activity of gyrase inhibitors norfoxacin, coumermycin A1 and nalidixic acid. Biochem Pharm 1988; 37: 1885-1886.
32. Portolani M, Pietrosemoli P, Cermelli C et al. Suppression of BK virus replication and cytopathic effect by inhibitors of prokaryotic DNA gyrase. Antiviral Res 1988; 9: 205-218.
33. Ost L, Lonnqvist B, Eriksson L et al. Haemorrhagic cystitis - a manifestation of graft versus host disease? Bone Marrow Transplantation 1987; 2: 19-25.
34. Gluck TA, Knowles WA, Johnson MA et al. BK virus-associated haemorrhagic cystitis in an HIV-infected man. AIDS 1994; 8: 391-392.
35. Barouch DH, Faquin WC, Chen Y et al. BK virus-associated haemorrhagic cystitis in a human immunodeficiency virus-infected patient. Clin Infect Dis 2002; 35: 326-329.
36. Leung AY, Chan M, Chen VC et al. Polyoma BK viruria in patients undergoing autologous hematopoietic stem cell transplantation. Bone Marrow Transplantation 2005; 35: 1029-1030.
37. Drummond JE, Shah KV, Saral R et al. BK virus specific humoral and cell mediated immunity in allogeneic bone marrow transplant (BMT) recipients. J Med Virol 1987; 23: 331-344.
38. Drummond JE, Shah KV, Donnenberg AD. Cell-mediated immune responses to BK virus in normal individuals. J Med Virol 1985; 17: 237-247.
39. Cheng VC, Yuen KY, Chan WM et al. Immunorestitution disease involving the innate and adaptive response. Clin Infect Dis 2000; 30: 882-892.
40. Akiyama H, Kurosu T, Sakashita C et al. Adenovirus is a key pathogen in haemorrhagic cystitis associated with bone marrow transplantation. Clin Infect Dis 2001; 32: 1325-1330.
41. Miyamura K, Takeyama K, Kojima S et al. Haemorrhagic cystitis associated with urinary excretion of adenovirus type 11 following allogeneic bone marrow transplantation. Bone Marrow Transplantation 1989; 4: 533-535.
42. Tutuncuoglu SO, Yanovich S, Ozdemirli M. CMV-induced haemorrhagic cystitis as a complication of peripheral blood stem cell transplantation: Case report. Bone Marrow Transplantation 2005 June 6.
43. Spach DH, Bauwens JE, Myerson D et al. Cytomegalovirus-induced haemorrhagic cystitis following bone marrow transplantation. Clin Infect Dis 1993; 16: 142-144.
44. Kristoffersen AK, Johnsen JI, Seternes OM et al. The human Polyomavirus BK T antigen induces gene expression in human cytomegalovirus. Virus Res 1997; 52: 61-71.
45. Ordemann R, Naumann R, Geissler G et al. Encouraging results in the treatment of haemorrhagic cystitis with estrogen-report of 10 cases and review of the literature. Bone Marrow Transplantation 2000; 25: 981-985.
46. Choong SK, Walkden M, Kirby R. The management of intractable haematuria. Br J Urol 2000; 86: 951-959.
47. Gine E, Rovira M, Real I et al. Successful treatment of severe haemorrhagic cystitis after hemopoietic cell transplantation by selective embolization of the vesical arteries. Bone Marrow Transplantation 2003; 31: 923-925.
48. Palandri F, Bonifazi F, Rossi C et al. Successful treatment of severe haemorrhagic cystitis with selective vesical artery embolization. Bone Marrow Transplantation 2005; 35: 529-530.
49. Sebe P, Garderet L, Traxer O et al. Subtotal cystectomy with ileocystoplasty for severe haemorrhagic cystitis after bone marrow transplantation. Urology 2001; 57: 168.
50. Garderet L, Bittencourt H, Sebe P et al. Cystectomy for severe hemorrhagic cystitis in allogeneic stem cell transplant recipients. Transplantation 2000; 70: 1807-1811.
51. Capelli-Schellpfeffer M, Gerber GS. The use of hyperbaric oxygen in urology. J Urol 1999; 162 (Part 1): 647-654.
52. Nagafuji K, Aoki K, Henzan H et al. Cidofovir for treating adenoviral haemorrhagic cystitis in hematopoietic stem cell transplant recipients. Bone Marrow Transplantation 2004; 34: 909-914.
53. Held TK, Biel SS, Nitsche A et al. Treatment of BK virus-associated haemorrhagic cystitis and simultaneous CMV reactivation with cidofovir. Bone Marrow Transplantation 2000; 26: 347-350.
54. Studemeister A. Cytomegalovirus-induced haemorrhagic cystitis in AIDS patient treated successfully with valganciclovir. AIDS 2002; 16: 1437-1438.
55. Blatt J, Gold SH, Wiley JM et al. Off-label use of recombinant factor VIIa in patients following bone marrow transplantation. Bone Marrow Transplantation 2001; 28: 405-407.
56. Karimi M, Zakerinia M, Khojasteh HN et al. Successful treatment of cyclophosphamide induced intractable haemorrhagic cystitis with recombinant FVIIa (NovoSeven) after allogeneic bone marrow transplantation. J Thromb Haemost 2004; 2: 1853-1855.
57. Demesmay K, Tissot E, Bulabois CE et al. Factor XIII replacement in stem-cell transplant recipients with severe haemorrhagic cystitis: A report of four cases. Transplantation 2002; 74: 1190-1192.
58. Fanourgiakis P, Georgala A, Vekemans M et al. Intravesical instillation of cidofovir in the treatment of haemorrhagic cystitis caused by adenovirus type 11 in a bone marrow transplant recipient. Clin Infect Dis 2005; 40: 199-201.
59. Ouwenga MK, Langston MD, Campbell SC. Use of fibrin sealant in recalcitrant haemorrhagic cystitis. J Urol 2004; 172: 1348.
60. Tunuguntla HS, Bhandari M, Srivastava A et al. Endoscopic injection sclerotherapy control of intractable Haematuria following radiation-induced haemorrhagic cystitis. A novel approach. Arch Esp Urol 2000; 53: 396-402.